feed,title,long_url,short_url
Benzinga,Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts,https://benzinga.com/general/biotech/22/08/28338368/analysts-are-bullish-on-sareptas-duchenne-gene-therapy-update,https://bit.ly/3zSp04w
Benzinga,"Uber Shares Gain As Analysts Cheer Q2 Performance, Free Cash Flow Feats",https://benzinga.com/news/22/08/28335641/uber-shares-gain-as-analysts-cheer-q2-free-cash-flow-feats,https://bit.ly/3PQPEQN
